Regulatory Filings • Nov 18, 2020
Regulatory Filings
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 20106-44-2020 |
Data/Ora Ricezione 18 Novembre 2020 08:06:01 |
AIM -Italia/Mercato Alternativo del Capitale |
||
|---|---|---|---|---|
| Societa' | : | Pharmanutra S.p.A. | ||
| Identificativo Informazione Regolamentata |
: | 139427 | ||
| Nome utilizzatore | : | PHARMANUTRAN02 - Lacorte Roberto | ||
| Tipologia | : | REGEM | ||
| Data/Ora Ricezione | : | 18 Novembre 2020 08:06:01 | ||
| Data/Ora Inizio Diffusione presunta |
: | 18 Novembre 2020 08:06:02 | ||
| Oggetto | : | Mauritius 18_11_2020 | PR - PHN agreement Greece, Cyprus and | |
| Testo del comunicato |
Vedi allegato.
Pisa, 18th November 2020 – After its recent agreement for distribution of SiderAL® products in Bolivia, PharmaNutra S.p.A. (AIM Ticker: PHN), communicates that it has signed another two new distribution agreements for the markets of Greece, Cyprus and the Mauritius Islands. A further, important step forward in its fast, ongoing, internationalisation process which currently sees the Italian company present in 57 foreign Countries,spread over four continents (Europa, Asia, America and Africa), thanks to collaboration with 39 important partners.
For what concerns Greece and Cyprus, the distribution agreement is for Cetilar® products - a Cetylated Ester-based (CFA) patented product line available in Italy in the cream, patch and tape with menthol versions – and was signed with WinMedica, a leading, Greek pharmaceutical company with which the PharmaNutra Group can boast profitable relationships. WinMedica has been distributing SiderAL® , a Sucrosomial® iron-based nutritional supplement since 2014 and Ultramag® Oro, a Sucrosomial® Magnesium-based product since 2017.
Cetilar® products - formulas that help reduce painful symptoms following traumas, contractures, pulled muscles, contusions or distortions, as well as recovering mobility, improving functionality and movement - will be available in Greece and Cyprus from spring 2021.
The agreement for the Mauritius Islands was signed with Ducray Lenoir, for distribution of Sucrosomial® based products in the archipelago. Operational since 1956 and focussed on pharmaceutical products since the start of the 90s, with a presence in Madagascar, Seychelles, Comoros, Rwanda, Eritrea and South Sudan, Ducray Lenoir will distribute SiderAL® Forte INT 20cps/box 30 mg Sucrosomial® Iron, leader in the iron-based nutritional supplements, in Mauritius.
"We have just reached three more foreign markets with our flagship brands, SiderAL® and Cetilar® ; result of the company's hard work even at a complicated time like the one we are all living", declares the COO of PharmaNutra S.p.a. Carlo Volpi. "They are extraordinary results confirming the scientific value of our products; and I like remembering that they are still part of an ongoing process. We have other important
international novelties in store and will take great pleasure in notifying our partners and investors as soon as they materialise".
Founded and led by the President Andrea Lacorte and Vice President Roberto Lacorte, PharmaNutra was established in 2003. It develops unique nutritional supplements and innovative nutritional devices, handling the entire production process, from proprietary raw materials to finished product. The efficacy of the products has been demonstrated with a wealth of scientific evidence, with 112 studies published involving more than 7000 subjects. The Group distributes and sells its products in Italy and abroad. In Italy, products are sold through a network of 140 Pharmaceutical Representatives serving doctors and also exclusively selling PharmaNutra products to pharmacies throughout Italy. Products are sold in over 50 countries abroad, through 34 partners selected from among the finest pharmaceutical companies. PharmaNutra leads the market in the production of iron-based nutritional supplements under the SiderAL® brand, where it boasts a number of important patents on Sucrosomial® technology. Over the years, the Group has developed a precise strategy for the management and production of intellectual property, founded on the integrated management of all the various elements: proprietary raw materials, patents, brands and clinical evidence. PharmaNutra.it
For information:
PharmaNutra S.p.A. Nomad
Via Delle Lenze, 216/b 56122 Pisa Tel. +39 050 7846500 [email protected] Internal Press Office [email protected]
CFO SIM S.p.A.
Via dell'Annunciata, 23/4 20121 Milan Tel. +39 02 303431 [email protected]om
Press Office Spriano Communication & Partners
Via Santa Radegonda, 16 20121 Milan Tel. +39 02 83635708
Matteo Russo [email protected] Cristina Tronconi [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.